1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Tibulizumab: new trials by email Literature Review of Tibulizumab trials Research Report on Tibulizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) Tibulizumab, Placebo - Systemic Sclerosis (SSc), Scleroderma | Phase 2 | Active not recruiting | Zura Bio Inc | 80 | 2025-02-06 | 2026-07-20 |
Autoimmune Diseases (1) · Immune System Diseases (1) · Lung Diseases, Interstitial (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1) · Skin Diseases (1)
Zura Bio Inc (1)
Argentina (1) · Chile (1) · Hungary (1) · Mexico (1) · Poland (1) · Romania (1) · Serbia (1) · Spain (1) · United Kingdom (1) · United States (1)